Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an app improve MS care? new study tests MSCopilot flower

NCT ID NCT06922942

Knowledge-focused Sponsor: Ad scientiam Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how well the MSCopilot Flower app works for people with multiple sclerosis. The app includes tests for walking, thinking, hand use, and vision, plus questionnaires about fatigue and anxiety. Researchers want to see if patients can use it easily at home and if doctors can integrate it into routine care. The study involves 60 participants in the US.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MSCopilot Flower mobile application
What this could lead to
If successful, this could show that a smartphone app can help doctors and patients monitor multiple sclerosis symptoms more easily at home.
What could go wrong
This is a small, early-stage study focused on usability, not on treating MS. The app may not work well for all patients or may not improve care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For patients * 18 years and older * With a confirmed and documented MS diagnosis, per the 2010 Revised * McDonald criteria * With an EDSS score ranging from 0 to 6.5 * Able to monitor their disease from home (i.e. not hospitalized or under medical assistance). * Having a personal smartphone with a mobile operating system above 16 for IOS (iPhone) and 8 for Android and having access to a good internet connection. * Able to read language in which the mobile application is available and able to understand pictograms Having read the information sheet and signed the informed consent form For HCPs: * Licensed neurologists trained in the management of Multiple Sclerosis patients and allowed to conduct clinical studies within their departments * If applicable: nurses or medical assistants specifically trained in the management of Multiple Sclerosis and allowed to participate in clinical studies within their departments * Ability to use a computer Exclusion Criteria (for patients): * Pregnant and nursing women * Person under guardianship or curatorship * Inability to use a smartphone application * Patient who previously participated in a study using MSCopilot Early termination criteria (for patients): * exclusion criteria, * death, * abandon, * loss of follow-up, * investigator's decision

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

Contacts and locations

Locations

  • Gabriel Pardo

    Oklahoma City, Oklahoma, 73104, United States

  • Jenny Feng

    New Orleans, Louisiana, 70121, United States

  • Leorah Freeman

    Austin, Texas, 78712, United States

  • Robert Naismith

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.